Russian President Vladimir Putin made the announcement on Wednesday, during a televised meeting with government officials. The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested on 100 volunteers. Russia plans to manufacture an initial 10000 doses, Vektor said, with production expected to begin in November.
Russia’s first vaccine, Sputnik V, was developed by the Gamaleya Institute in Moscow and approved by the government in August.
According to Russia’s Health Ministry, about 400 high-risk patients have received the Sputnik V vaccine.
- Key things about Russia s second COVID 19 vaccine EpiVacCorona
- Key things about Russia’s second COVID-19 vaccine EpiVacCorona
- President Putin says Russia is ‘first’ to develop coronavirus vaccine
- Vietnam to negotiate with Russia to buy 40 million Covid-19 vaccine doses
- Russia names its first COVID-19 vaccine ‘Sputnik V’
- First group of elderly volunteers injected with Sputnik V vaccine
- Russia’s COVID-19 vaccine pre-ordered by 20 nations for a billion doses
- Vietnam receives 1,000 doses of Russia-made Sputnik V vaccine
- Russia to discuss Sputnik-V production cooperation with Vietnam
- Covid 19 vaccine update Controversial Russia s Sputnik V and its availability